MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-10-0004929
Stenkem Molecules Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.1 Cr
▼ 15% YoY
Net loss · FY 2025
₹8.39 Lakh
Net margin -4%
EBITDA · FY 2025
-₹7 Lakh
EBITDA margin -3.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Stenkem Molecules Private Limited
Data last updated:
Stenkem Molecules Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24303HR2018PTC075659. Its GSTIN is 06ABACS7906F1ZF (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sachin Ahuja and Rajesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Karnal, Haryana.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.1 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹8.39 Lakh (net margin -4%) and EBITDA of -₹7 Lakh (EBITDA margin -3.3%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 14% over five years.
Stenkem Molecules Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0004929). For more details, the company can be reached via its website stenkemmolecules.com.
Company Details of Stenkem Molecules Private Limited
CIN U24303HR2018PTC075659
Registration Number 075659
Incorporation Date 11 September 2018
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-10-0004929
Recognitions & Rankings of Stenkem Molecules
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No – 335 First Floor Sector – 3A Phase – II Industrial Area H, Siidc, Karnal, Haryana, India – 132001
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Stenkem Molecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Stenkem Molecules Private Limited FY 2025 filings available
Stenkem Molecules Private Limited reported revenue of ₹2.1 Cr (down 15% YoY) for FY 2025.
Revenue · FY 2025
₹2.1 Cr ▼ 15%
Net loss · FY 2025
₹8.39 Lakh margin -4%
EBITDA · FY 2025
-₹7 Lakh margin -3.3%
Compounded Annual Growth Rate (CAGR) of Stenkem Molecules Private Limited
Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▼ 8%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 157%
3 years · compounded
▼ 52%
5 years · compounded
▼ 58%
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stenkem Molecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8.39 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stenkem Molecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stenkem Molecules are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Stenkem Molecules Private Limited
Stenkem Molecules has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Ahuja Also directs: Serbia Molecules Private Limited | Director | 20 Jan 2022 | 4 Years 9 Months | Current |
| Rajesh Kumar Also directs: Semmax Printing Private Limited, Stenkem Biolife Private Limited | Director | 11 Sep 2018 | 8 Years 1 Months | Current |
| Pooja Ahuja | Director | 20 Jan 2022 | 4 Years 9 Months | Current |
| Sangeeta Rani Also directs: Semmax Printing Private Limited, Stenkem Biolife Private Limited | Director | 01 Mar 2022 | 4 Years 7 Months | Current |
Auditor Details of Stenkem Molecules Private Limited
Stenkem Molecules Private Limited is audited by GROVER DINESH & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GROVER DINESH & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Stenkem Molecules Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stenkem Molecules Private Limited
Stenkem Molecules Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Stenkem Molecules Private Limited
Employment history and EPFO contributions of people linked to Stenkem Molecules.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stenkem Molecules Private Limited
Stenkem Molecules Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Kapil Ahuja ceased to be Director on 02 Mar 2022.
AGM
Stenkem Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stenkem Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Kapil Ahuja ceased to be Director.
Appointed
Sangeeta Rani was appointed as Director.
Appointed
Pooja Ahuja was appointed as Director.
Appointed
Sachin Ahuja was appointed as Director.
Ceased
Sangeeta Rani ceased to be Director.
Appointed
Rajesh Kumar was appointed as Director.
Incorporation
11 Sep 2018
Stenkem Molecules Private Limited was registered on 11 Sep 2018 with Roc Haryana & aged 8 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Stenkem Molecules Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stenkem Molecules Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stenkem Molecules Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stenkem Molecules Private Limited
Stenkem Molecules has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06ABACS7906F1ZF | Haryana | Active | 13 Oct 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stenkem Molecules Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stenkem Molecules Private Limited
Stenkem Molecules is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 September 2018 (8+ years old) and is registered under CIN U24303HR2018PTC075659.
Stenkem Molecules reported revenue of ₹2.1 Cr for FY 2025 (down 15% YoY).
Stenkem Molecules has 4 current directors:
- Sachin Ahuja - Director
- Rajesh Kumar - Director
- Pooja Ahuja - Director
- Sangeeta Rani - Director
Stenkem Molecules reported a net loss of ₹8.39 Lakh (net margin -4%) and EBITDA of -₹7 Lakh (EBITDA margin -3.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stenkem Molecules is -8% over three years and 14% over five years. In the latest year (FY 2025) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Stenkem Molecules is 06ABACS7906F1ZF, registered in Haryana.
The CIN (Corporate Identification Number) of Stenkem Molecules is U24303HR2018PTC075659. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stenkem Molecules was incorporated on 11 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Haryana.
Kapil Ahuja ceased to be Director on 02 Mar 2022. Sangeeta Rani was appointed as Director on 01 Mar 2022. Pooja Ahuja was appointed as Director on 20 Jan 2022. Stenkem Molecules has 6 board changes on record in total.
Yes, Stenkem Molecules is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-10-0004929).